The first human trial in Europe of a coronavirus vaccine has begun in Oxford University in the UK.
BBC News reports two volunteers were injected, the first of more than 800 people recruited for the study.
Half will receive the COVID-19 vaccine, and half a control vaccine which protects against meningitis but not coronavirus.
The design of the trial means volunteers will not know which vaccine they are getting, though doctors will.
The vaccine was developed in under three months by a team at Oxford University. They could find out if it works after more than a year.
[Source: BBC]
